Skip to main content

Table 1 Examples of genome-wide linkage studies of osteoporosis and related traits*

From: Genome-wide approaches for identifying genetic risk factors for osteoporosis

Study participants

No. of markers

Phenotype

Results

Refs

3,730 men and 4,374 women from the Framingham Osteoporosis Study

209,546 SNPs. Genotypic call rates ≥97%, HWE P ≥ 0.01; MAF ≥0.2

Hip and spine BMD heel ultrasound, geometric indices of the hip

For BMD, 9p and 11p, LOD ≥3.0; for ultrasound, 4p, LOD = 3.9, 16p, LOD = 3.8, 22p, LOD = 4.0; for femoral neck width, 7p, LOD ≥5.0

[23]

4,498 individuals from 451 pedigrees

410

TBLM and spine BMD in women

15q13, LOD = 4.86

[19]

  

TBLM and spine BMD

7p22, LOD >2.2; Xq25, LOD >3.5

[19]

  

TBLM and BMD at both spine and hip in women

7q32, LOD = 2.67

[19]

  

TBLM and BMD at both spine and hip in men

7q21, LOD = 2.52; 13p11, LOD = 325

[19]

1,323 individuals from 207 extended Icelandic families

1,100

Hip BMD

16q, LOD = 1.99

[16]

  

Spine BMD

18p, LOD = 2.12

[16]

664 individuals from 29 Mexican-American families

416

Forearm BMD

4p, LOD = 4.33; 12q, LOD = 2.35

[17]

  

Trochanter BMD in both men and women

6p, LOD = 2.27

[17]

  

Neck BMD only in men

2p, LOD = 3.98

[17]

  

Trochanter BMD only in men

13q, LOD = 3.46

[17]

11,842 individuals from 9 groups

Varied between 270 and 1,008

Lumbar spine BMD only in women; lumbar spine BMD in both women and men; femoral neck BMD

LOD >1.6 for 1p13.3-q23.3, 12q24.31-qter, 3p25.3-p22.1, 11p12-q13.3, 1q32-q42.3, 18p11-q12.3, 9q31.1-q33.3, 17p12-q21.33, 14q13.1-q24.1, 9q21.32-q31.1, and 5q14.3-q23.2

[22]

  1. *HWE P, Hardy-Weinberg Equilibrium P-value; LOD, logarithm of odds; MAF, minor allele frequency; TBLM, total body lean mass.